TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Singapore Tele-technology Aided Rehabilitation in Stroke (STARS) Study: A Randomized Controlled Trial
Brief Summary: The primary hypothesis tested in this randomized control trial is that a tele-rehabilitation intervention involving video-conferencing with a therapist and use of wearable monitoring devices in the first three months after stroke results greater functional recovery using the Jette Late Life Functional and Disability Instrument (LLFDI) (primary outcome) among stroke at three months survivors compared to usual care.

The secondary hypotheses tested in this randomized control trial are that a tele-rehabilitation intervention involving video-conferencing with a therapist and use of wearable monitoring devices in the first three months after stroke results in:

* Functional recovery using the LLFDI at 6 months,
* Functional recovery using gait speed, 2-minute walk test and Shah modified Barthel Index at 3 and 6 months,
* Greater contact time with a therapist at 3 \& 6 months,
* Better balance at 3 \& 6 months,
* Better self-report health-related quality of life at 3 \& 6 months,
* Decreased health service utilization at 3 \& 6 months,
* Reduced caregiver burden at three months survivors compared to usual care at 3 \& 6 months.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Tele-Rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Tele-rehabilitation | Intervention Type: OTHER; Name: Tele-rehabilitation; Assigned to Arm(s): Tele-Rehabilitation
B: Arm Label: Aphasia telerehabilitation; Type: EXPERIMENTAL; Interventions: Other: Aphasia telerehabilitation, Other: Standard face-to-face aphasia rehabilitation | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard face-to-face aphasia rehabilitation | Intervention Type: OTHER; Name: Aphasia telerehabilitation; Assigned to Arm(s): Aphasia telerehabilitation | Intervention Type: OTHER; Name: Standard face-to-face aphasia rehabilitation; Assigned to Arm(s): Aphasia telerehabilitation, Control
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SCM; Type: EXPERIMENTAL; Interventions: Other: SCM | Arm Label: SCM and VSSP; Type: EXPERIMENTAL; Interventions: Other: SCM and VSSP | Intervention Type: OTHER; Name: SCM; Assigned to Arm(s): SCM | Intervention Type: OTHER; Name: SCM and VSSP; Assigned to Arm(s): SCM and VSSP
D: Arm Label: effects of a incentive program for physical activity; Type: EXPERIMENTAL; Interventions: Other: incentive program for physical activity | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: incentive program for physical activity; Assigned to Arm(s): effects of a incentive program for physical activity

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Singapore Tele-technology Aided Rehabilitation in Stroke (STARS) Study: A Randomized Controlled Trial
Brief Summary: The primary hypothesis tested in this randomized control trial is that a tele-rehabilitation intervention involving video-conferencing with a therapist and use of wearable monitoring devices in the first three months after stroke results greater functional recovery using the Jette Late Life Functional and Disability Instrument (LLFDI) (primary outcome) among stroke at three months survivors compared to usual care.

The secondary hypotheses tested in this randomized control trial are that a tele-rehabilitation intervention involving video-conferencing with a therapist and use of wearable monitoring devices in the first three months after stroke results in:

* Functional recovery using the LLFDI at 6 months,
* Functional recovery using gait speed, 2-minute walk test and Shah modified Barthel Index at 3 and 6 months,
* Greater contact time with a therapist at 3 \& 6 months,
* Better balance at 3 \& 6 months,
* Better self-report health-related quality of life at 3 \& 6 months,
* Decreased health service utilization at 3 \& 6 months,
* Reduced caregiver burden at three months survivors compared to usual care at 3 \& 6 months.


Options:
A: Arm Label: mod. Constraint-Induced Movement Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: mod. Constraint-Induced Movement Therapy | Arm Label: Therapy as usual; Type: OTHER; Interventions: Other: Therapy as usual | Intervention Type: BEHAVIORAL; Name: mod. Constraint-Induced Movement Therapy; Assigned to Arm(s): mod. Constraint-Induced Movement Therapy | Intervention Type: OTHER; Name: Therapy as usual; Assigned to Arm(s): Therapy as usual
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Family Mediated Exercise Therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Family Mediated Exercise Therapy; Assigned to Arm(s): 1
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Tele-Rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Tele-rehabilitation | Intervention Type: OTHER; Name: Tele-rehabilitation; Assigned to Arm(s): Tele-Rehabilitation
D: Arm Label: Self-Directed Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-directed program | Arm Label: Stroke Support Person; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Timing it Right Stroke Family Support Person Intervention | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Timing it Right Stroke Family Support Person Intervention; Assigned to Arm(s): Stroke Support Person | Intervention Type: BEHAVIORAL; Name: Self-directed program; Assigned to Arm(s): Self-Directed Program

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Assess the Pharmacodynamic Response, Safety, and Tolerability to 20 Weeks of Oral Dosing of AKB-6548 in Participants With Anemia Secondary to Chronic Kidney Disease (CKD), GFR Categories G3a-G5 (Stages 3, 4, AND 5) (Pre-Dialysis)
Brief Summary: The purpose of this study is to evaluate the hemoglobin response (efficacy), safety, and tolerability of orally administered AKB-6548 in participants with Chronic Kidney Disease (pre-dialysis) with anemia with dosing for 20 weeks.


Options:
A: Arm Label: 0.5mg GSK1278863; Type: EXPERIMENTAL; Interventions: Drug: GSK1278863 | Arm Label: 2mg GSK1278863; Type: EXPERIMENTAL; Interventions: Drug: GSK1278863 | Arm Label: 5mg GSK1278863; Type: EXPERIMENTAL; Interventions: Drug: GSK1278863 | Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Other: Placebo | Intervention Type: DRUG; Name: GSK1278863; Assigned to Arm(s): 0.5mg GSK1278863, 2mg GSK1278863, 5mg GSK1278863 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Roxadustat; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Roxadustat; Assigned to Arm(s): Roxadustat | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: AKB-6548; Type: EXPERIMENTAL; Interventions: Drug: AKB-6548 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AKB-6548; Assigned to Arm(s): AKB-6548 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Daprodustat receivers; Type: EXPERIMENTAL; Interventions: Drug: Daprodustat (GSK1278863), Drug: Iron therapy | Arm Label: Placebo receivers; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Iron therapy | Intervention Type: DRUG; Name: Daprodustat (GSK1278863); Assigned to Arm(s): Daprodustat receivers | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo receivers | Intervention Type: DRUG; Name: Iron therapy; Assigned to Arm(s): Daprodustat receivers, Placebo receivers

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Parenting Programs on Child Development and Maternal Well-being in Rural Uganda
Brief Summary: The purpose of the current study involves the development, implementation and evaluation of a parenting program to target maternal well-being and child health, growth and development in Lira, Uganda. The current study aims to address maternal care within a parenting program as well as parenting practices emphasizing nutrition, hygiene, and psychosocial stimulation through peer-support, practice and problem-solving. Outcomes include child health, growth and development, maternal mental health, mother-child interactions, and maternal-spousal relations.

We hypothesize that:

1. Children of parents who attend the parenting program will have better health, height and cognitive/language development at post-test, than children whose parents did not have the opportunity to attend parenting sessions.
2. Parents who attend the parenting program will have more knowledge about child development and provide more home stimulation, dietary diversity and preventive health practices than parents who do not have the opportunity to attend parenting sessions.
3. Mothers who attend the parenting program will have improved well-being compared to mothers who do not have the opportunity to attend parenting sessions.


Options:
A: Arm Label: Parenting Program; Type: EXPERIMENTAL; Interventions: Behavioral: Parenting Program | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Parenting Program; Assigned to Arm(s): Parenting Program
B: Arm Label: Maternal support to become mother; Type: EXPERIMENTAL; Interventions: Behavioral: Maternal support to become mother | Arm Label: Control group: usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Group: usual care | Intervention Type: BEHAVIORAL; Name: Maternal support to become mother; Assigned to Arm(s): Maternal support to become mother | Intervention Type: BEHAVIORAL; Name: Control Group: usual care; Assigned to Arm(s): Control group: usual Care
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: ACT Intervention; Type: EXPERIMENTAL; Interventions: Other: ACT | Intervention Type: OTHER; Name: ACT; Assigned to Arm(s): ACT Intervention
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced usual care | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PRIDE 'Step 1' problem-solving intervention | Intervention Type: BEHAVIORAL; Name: PRIDE 'Step 1' problem-solving intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Enhanced usual care; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Increase Protein Intake in Elderly
Brief Summary: The objective of this study is to investigate the acceptance, intake, and compliance of protein enriched bread and protein enriched yoghurt drinks in elderly patients in two real life settings (short term; hospital, and longer term; rehabilitation home).


Options:
A: Arm Label: Dietary Advice; Type: OTHER; Interventions: Behavioral: Dietary Advice | Arm Label: Oral Nutritional Supplements; Type: OTHER; Interventions: Dietary Supplement: Oral Nutritional Supplements (Fortisip) | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Dietary Advice | Intervention Type: DIETARY_SUPPLEMENT; Name: Oral Nutritional Supplements (Fortisip); Assigned to Arm(s): Oral Nutritional Supplements
B: Intervention Type: BEHAVIORAL; Name: Nutritional programme; Assigned to Arm(s): N/A
C: Intervention Type: PROCEDURE; Name: family style dinner; Assigned to Arm(s): N/A
D: Arm Label: Protein enriched yoghurt drink and bread; Type: EXPERIMENTAL; Interventions: Other: Protein enriched yoghurt drink and bread | Arm Label: Regular yoghurt drink and bread; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Protein enriched yoghurt drink and bread; Assigned to Arm(s): Protein enriched yoghurt drink and bread

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
Brief Summary: Preventing psychotic disorders such as schizophrenia and associated functional disability could relieve an enormous burden of personal and family suffering and economic losses to society. This project aims to conduct a pilot randomized trial to determine the efficacy of a family-focused treatment in comparison with treatment-as-usual in enhancing functional outcomes, stabilizing symptoms, and preventing or delaying the onset of full psychosis in transitional age youth with prodromal symptoms. The results of this study will be crucial for the development of cost-effective, evidence-based psychosocial approaches to psychosis prevention and thus will have major implications for public health.


Options:
A: Arm Label: Cognitive Remediation Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Remediation Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Remediation Therapy; Assigned to Arm(s): Cognitive Remediation Therapy
B: Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): N/A
C: Arm Label: treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: treatment as usual | Arm Label: Psychoeducation Group; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducation group treatment | Intervention Type: BEHAVIORAL; Name: treatment as usual; Assigned to Arm(s): treatment as usual | Intervention Type: BEHAVIORAL; Name: Psychoeducation group treatment; Assigned to Arm(s): Psychoeducation Group
D: Arm Label: Family Focused Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Family Focused Treatment | Arm Label: Enhanced Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Care | Intervention Type: BEHAVIORAL; Name: Family Focused Treatment; Assigned to Arm(s): Family Focused Treatment | Intervention Type: BEHAVIORAL; Name: Enhanced Care; Assigned to Arm(s): Enhanced Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
Brief Summary: Preventing psychotic disorders such as schizophrenia and associated functional disability could relieve an enormous burden of personal and family suffering and economic losses to society. This project aims to conduct a pilot randomized trial to determine the efficacy of a family-focused treatment in comparison with treatment-as-usual in enhancing functional outcomes, stabilizing symptoms, and preventing or delaying the onset of full psychosis in transitional age youth with prodromal symptoms. The results of this study will be crucial for the development of cost-effective, evidence-based psychosocial approaches to psychosis prevention and thus will have major implications for public health.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Family-aided Assertive Community Treatment; Type: EXPERIMENTAL; Interventions: Drug: aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine, Behavioral: Psychoeducational multifamily group treatment, Behavioral: Supported employment and education | Intervention Type: DRUG; Name: aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine; Assigned to Arm(s): Family-aided Assertive Community Treatment | Intervention Type: BEHAVIORAL; Name: Psychoeducational multifamily group treatment; Assigned to Arm(s): Family-aided Assertive Community Treatment | Intervention Type: BEHAVIORAL; Name: Supported employment and education; Assigned to Arm(s): Family-aided Assertive Community Treatment
B: Arm Label: Self-learning program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-learning program | Arm Label: Psycho-education (in Phase 2); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psycho-education program (in Phase 2) | Arm Label: Routine community care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-learning program; Assigned to Arm(s): Self-learning program | Intervention Type: BEHAVIORAL; Name: Psycho-education program (in Phase 2); Assigned to Arm(s): Psycho-education (in Phase 2)
C: Arm Label: Family Focused Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Family Focused Treatment | Arm Label: Enhanced Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Care | Intervention Type: BEHAVIORAL; Name: Family Focused Treatment; Assigned to Arm(s): Family Focused Treatment | Intervention Type: BEHAVIORAL; Name: Enhanced Care; Assigned to Arm(s): Enhanced Care
D: Intervention Type: BEHAVIORAL; Name: Integrated treatment, family involvement; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Social skills training; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
Brief Summary: This trial is a pilot study to determine the feasibility of a randomized clinical trial comparing a treatment algorithm consisting of a limited number of clinical parameters, rapid molecular viral diagnostics, and serum procalcitonin testing to standard of care for directing antibiotic use in patients with non-pneumonic lower respiratory tract infection. The reduction in antibiotic use in those subjects randomized to the treatment algorithm compared to those randomized to standard care will be determined.


Options:
A: Arm Label: PCT; Type: EXPERIMENTAL; Interventions: Behavioral: a strategy based on PCT guided AB therapy | Arm Label: Guidelines; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: a strategy based on PCT guided AB therapy | Intervention Type: BEHAVIORAL; Name: a strategy based on PCT guided AB therapy; Assigned to Arm(s): Guidelines, PCT
B: N/A
C: Intervention Type: PROCEDURE; Name: PCT measurement; Assigned to Arm(s): N/A
D: Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Release of test results; Type: EXPERIMENTAL; Interventions: Other: Release of test results | Intervention Type: OTHER; Name: Release of test results; Assigned to Arm(s): Release of test results

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Role of Rapid Diagnostic Tests for Malaria for Targeting of ACTs at Community Level: a Cluster Randomized Trial
Brief Summary: This study aims to test directly by means of a cluster randomized controlled trial, the impact of the introduction of RDTs for malaria on dispensing behaviour of chemical sellers, the main non-formal outlet for drugs locally, at community level.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Coartem and amoxicillin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Coartem | Intervention Type: DRUG; Name: Coartem and amoxicillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Coartem; Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Rapid diagnostic test for malaria | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Rapid diagnostic test for malaria | Intervention Type: DEVICE; Name: Rapid diagnostic test for malaria; Assigned to Arm(s): 1, 2
C: Arm Label: Rapid Diagnostic Test; Type: EXPERIMENTAL; Interventions: Procedure: Rapid Diagnostic Test | Arm Label: No RDT; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Rapid Diagnostic Test; Assigned to Arm(s): Rapid Diagnostic Test
D: Arm Label: Current Practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Arm; Type: ACTIVE_COMPARATOR; Interventions: Device: Malaria Rapid Diagnostic test | Intervention Type: DEVICE; Name: Malaria Rapid Diagnostic test; Assigned to Arm(s): Intervention Arm

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Systemic lidocaine infusion may improve the patients' recovery quality and chronic post surgical pain after robot-assisted thyroidectomy


Options:
A: Arm Label: 0.25% Ropivicaine; Type: EXPERIMENTAL; Interventions: Drug: Ropivicaine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline placebo | Intervention Type: DRUG; Name: Saline placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Ropivicaine; Assigned to Arm(s): 0.25% Ropivicaine
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 5; Type: PLACEBO_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Intervention Type: PROCEDURE; Name: perioperative epidural catheter; Assigned to Arm(s): 1, 2, 3, 4, 5
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Lidocaine; Type: EXPERIMENTAL; Interventions: Drug: Lidocaine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Lidocaine
D: Arm Label: Group L; Type: EXPERIMENTAL; Interventions: Drug: Systemic intravenous lidocaine infusion | Arm Label: Group C; Type: PLACEBO_COMPARATOR; Interventions: Drug: normal saline infusion | Intervention Type: DRUG; Name: Systemic intravenous lidocaine infusion; Assigned to Arm(s): Group L | Intervention Type: DRUG; Name: normal saline infusion; Assigned to Arm(s): Group C

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Systemic lidocaine infusion may improve the patients' recovery quality and chronic post surgical pain after robot-assisted thyroidectomy


Options:
A: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: ketamine | Intervention Type: DRUG; Name: ketamine; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 1
B: Arm Label: Patients who had inguinal herniorraphy.; Type: N/A; Interventions: Procedure: Inguinal herniorraphy. | Arm Label: Patients who had hysterectomy.; Type: N/A; Interventions: Procedure: Hysterectomy. | Arm Label: Patients who had thoracotomy.; Type: N/A; Interventions: Procedure: Thoracotomy . | Intervention Type: PROCEDURE; Name: Inguinal herniorraphy.; Assigned to Arm(s): Patients who had inguinal herniorraphy. | Intervention Type: PROCEDURE; Name: Hysterectomy.; Assigned to Arm(s): Patients who had hysterectomy. | Intervention Type: PROCEDURE; Name: Thoracotomy .; Assigned to Arm(s): Patients who had thoracotomy.
C: Arm Label: Group L; Type: EXPERIMENTAL; Interventions: Drug: Systemic intravenous lidocaine infusion | Arm Label: Group C; Type: PLACEBO_COMPARATOR; Interventions: Drug: normal saline infusion | Intervention Type: DRUG; Name: Systemic intravenous lidocaine infusion; Assigned to Arm(s): Group L | Intervention Type: DRUG; Name: normal saline infusion; Assigned to Arm(s): Group C
D: Arm Label: ropivacaine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: infiltration with ropivacaine solution | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: infiltration with ropivacaine solution | Intervention Type: PROCEDURE; Name: infiltration with ropivacaine solution; Assigned to Arm(s): placebo, ropivacaine

Answer: C